Multicomponent therapeutics for networked systems
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Therapeutic regimens that comprise more than one active ingredient are commonly used in clinical medicine. Despite this, most drug discovery efforts search for drugs that are composed of a single chemical entity. A focus in the early drug discovery process on identifying and optimizing the activity of combinations of molecules can result in the identification of more effective drug regimens. A systems perspective facilitates an understanding of the mechanism of action of such drug combinations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“combinations of chemical agents (or manipulations such as those of transcription factors that affect multiple steps in a pathway [1906] or modulation of multiple gene products [2311], or both [2312,2313]) will be far more efficacious, for instance in modulating iron-catalysed oxidative stress and its sequelae, than will be the use of 'magic bullet' single agents.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1705]
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 1×
“There have been attempts to systematize a set of principles that can account for combination drugs that exist toda”
BackgroundLessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundBlume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Transcriptional Regulatory Networks in Saccharomyces cerevisiae
Lee, T. I., Rinaldi, N. J., Robert, F., Odom, D. T., Bar-Joseph, Z., Gerber, G. K., Hannett, N. M., Harbison, C. T., Thompson, C. M., Simon, I., et al. (2002) · Science · doi:10.1126/science.1075090 · Cited by 2,956
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419 · cited 1×
“Numerous researchers have attempted to provide an unambiguous framework for the calculation of additive effects between compounds; these approaches are reviewed comprehensively elsewher”
BackgroundSystematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Self-citation
Research works printed but not linked: 2
- Ehrlich, P. Chemotherapeutics: scientific principles, methods and results. Lancet 2, 445–451 (1913).
- Albert, A. Selective Toxicity (Methuen & Co., London, 1968).
Cited by
Items 501–600 of 799
Coa, J. C., Cardona‐Galeano, W., & Restrepo, A. A. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp04174a · Cited by 11
Spontaneous fistulization of hepatic hydatid cyst into the duodenum: an exceptional complication.
Daldoul, S., Moussi, A., & Zaouche, A. (2013) · PubMed · Cited by 13
Gao, J., Fu, Y., Song, L., Long, M., Zhang, Y., Qin, J., & Liu, H. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500239 · Cited by 11
Li, B., Wang, Y., Gu, H., Yu, Y., Wang, P., Liu, J. H., Zhang, Y., Chen, Y., Niu, Q., Wang, B., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.813983 · Cited by 11
Ligeti, B., Pénzváltó, Z., Alvarez, R. V., Győrffy, B., & Pongor, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129267 · Cited by 13
“The number of approved drug combinations is on the increase, even though most of them were established by experience and intuition [7, 8].”
BackgroundGerber, S., Assmus, H. E., Bakker, B. M., & Klipp, E. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.09.027 · Cited by 12
Multidimensional profiling in the investigation of small-molecule-induced cell death
Wolpaw, A. J., & Stockwell, B. R. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801430-1.00011-1 · Cited by 10
Self-citationSrithanyarat, T., Taoma, K., Sutthibutpong, T., Ruengjitchatchawalya, M., Liangruksa, M., & Laomettachit, T. (2024) · BioData Mining · doi:10.1186/s13040-024-00359-z · Cited by 10
Lekhan, A., & Turner, R. J. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01047-24 · Cited by 12
“While the combinational approach had already demonstrated promising results since the early 2000s in treat ment of tuberculosis (7), HIV (8), cancer (9), and malaria (10), the single multitarget antimicrobial agents’ field is just starting to receive attention.”
Elshami, F. I., Elrefaei, G., Ibrahim, M. M., El‐Mehasseb, I. M., & Shaban, S. Y. (2024) · Carbohydrate Research · doi:10.1016/j.carres.2024.109207 · Cited by 10
Naruo, Y., Nagashima, T., Ushikoshi‐Nakayama, R., Saeki, Y., Nakakuki, T., Naka, T., Tanaka, H., Tsai, S., & Okada, M. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-29 · Cited by 13
“Classification of additive, antagonistic, or synergistic effect is determined by comparing the response to a combinatorial perturbation with that to a single perturbation [39,40].”
BackgroundA Phenolic Antioxidant Releasing Nitric Oxide on Demand
Vittorino, E., & Sortino, S. (2009) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200901207 · Cited by 10
Guedes, G. M. D. M., Albuquerque, R. S., Soares-Maciel, R. S., de Freitas, M. A., Silva, V. A., Lima, E. D. O., Lima, M. A., da Cunha, E. V. L., & Coutinho, H. D. M. (2014) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2014.10.014 · Cited by 10
“The phenomena of antibiotic resistance are increasing despite the advances in the development of new drugs (Keith et al., 2005) and the combination with natural products of plants that can alter the effect of antibiotics, either increasing or decreasing the antibiotic activity can be an interesting alternative to over…”
BackgroundChoedon, T., Dolma, D., Ganeshan, M., & Kumar, V. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-380 · Cited by 10
“TTM are mostly multi-ingredient formulation comprising 3 to 150 herbs and minerals to combat multifactorial diseases like cancer [9].”
RetractedAssessing Combinational Drug Efficacy in Cancer Cells by Using Image-based Dynamic Response Analysis
Sima, C., Hua, J., Cypert, M., Miller, T. M., Wilson-Robles, H. M., Trent, J. M., Dougherty, E. R., & Bittner, M. L. (2015) · Cancer Informatics · doi:10.4137/cin.s30799 · Cited by 11
“To optimize live/dead classifying accuracy late in response, we combined Equations (4) and (5).”
BackgroundInfluentialRoberts, C. A., Miller, J. H., & Atkinson, P. H. (2017) · FEMS Yeast Research · doi:10.1093/femsyr/fox027 · Cited by 10
Kumar, V., Sharma, A., Pratap, S., & Kumar, P. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.10.017 · Cited by 10
Ma, X., Wu, J., Liu, C., Li, J., Dong, S., Zhang, X., Wang, J., Liu, L., Zhang, X., Sun, P., et al. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/4931531 · Cited by 10
Maqbool, T., Hadi, F., Razzaq, S., Naz, S., Aftab, S., Khurshid, S., Awan, S. J., Nawaz, A., Abid, F., & Malik, A. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.3.843 · Cited by 10
“Many people have envisioned drug combinations as promising methods of treating complex diseases such as inflammation, cancer and type 2 diabetes (Feala et al., 2010; Fitzgerald et al., 2006; Keith et al., 2005).”
BackgroundThe Intersection of Strategy and Drug Research
Moos, W. H. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00033-x · Cited by 14
Morris, A., Hoyle, R. G., Pagare, P. P., Zaman, S. U., Ma, Z., Li, J., & Zhang, Y. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105812 · Cited by 10
Fu, X., Lu, R., & Zhao, S. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_141_16 · Cited by 10
“Herbal formula is the basis of traditional Chinese medicine (TCM), and multi-herb is the characteristic of formula which used as one component to treat disease according to the TCM theory.[1,2] However, quality control of the TCM formula is difficult because of a large amount of the ingredients, especially of the unkn…”
BackgroundComputational Modeling of Multi-target-Directed Inhibitors Against Alzheimer’s Disease
Kumar, A., & Sharma, A. K. (2017) · Neuromethods · doi:10.1007/978-1-4939-7404-7_19 · Cited by 12
Medicinal Plants as Novel Promising Therapeutics for Neuroprotection and Neuroregeneration
Kaur, G., Kataria, H., & Mishra, R. (2018) · Springer eBooks · doi:10.1007/978-981-10-8291-7_20 · Cited by 11
Therapeutically relevant natural products as AMPK activators in the treatment of diabetes
Germán-Acacio, J. M., Meza-Sánchez, D. E., & Morales‐Morales, D. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-817907-9.00003-9 · Cited by 15
Overcoming Drug Resistance by Phytochemicals
Chan, M. M.-Y., & Fong, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-89445-4_14 · Cited by 10
Chemical Tools for Indications Discovery
Hopkins, A. L., Lanfear, J., Lipinski, C. A., & Beeley, L. J. (2005) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(05)40022-6 · Cited by 10
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
Pereira, A. M., de Souza, C. F. M., Álvarez-Córdoba, M., Reche-López, D., & Sánchez-Alcázar, J. A. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03453-x · Cited by 9
“Many monotherapies have limitations that can be overcome by attacking the disease system in multiple ways [62].”
Wali, A. F., Talath, S., Babiker, R., El‐Tanani, M., Rangraze, I. R., Ibraheem, W., Al-Dhaheri, Y., Satyam, S. M., & El‐Tanani, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1764550 · Cited by 10
“The second tactic involves creating medications target numerous oncogenic pathways simultaneously to effectively inhibit them all (Keith et al., 2005).”
Ma, J., Wang, X., & Sun, Q. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1782874 · Cited by 11
“This broad-spectrum modulation complicates the cancer cell’s ability to develop resistance via single-pathway mutations (Keith et al., 2005) (Figure 1).”
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
Hany, D., Zoetemelk, M., Bhattacharya, K., Nowak-Sliwinska, P. M., & Picard, D. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04730-x · Cited by 9
“Drug combinations involve the multi-dimensional targeting of biological networks (Keith et al, 2005; Weiss et al, 2019), which increases the efficacy and reduces the likelihood of developing resistance to the simultaneously used drugs (Bozic et al, 2013).”
BackgroundShi, S., Xu, M., Zhao, Y., Feng, L., Liu, Q., Yao, Z., Sun, Y., Zhou, T., & Ye, J. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00186 · Cited by 9
Chen, T., Wei, Y., Yin, S., Li, W., Wang, Y., Pi, C., Zeng, M., Wang, X., Chen, L., Liu, F., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s474158 · Cited by 9
“19 While practical, this approach is fraught with limitations.”
BackgroundBioMOF@cellulose Glycerogel Scaffold with Multifold Bioactivity: Perspective in Bone Tissue Repair
Rosado, A., Borrás, A., Sánchez-Soto, M. Á., Labíková, M., Hettegger, H., Ramírez-Jiménez, R. A., Rojo, L., García‐Fernández, L., Aguilar, M. R., Liebner, F. W., et al. (2024) · Gels · doi:10.3390/gels10100631 · Cited by 9
“Remarkably, it was demonstrated that CaSyr-1 enables the development of triple therapeutic entities, involving bioactive Ca 2+ , syringic acid, and an impregnated drug, which supports the development of therapeutic regimens based on multiple drugs for the treatment of particular diseases [19].”
BackgroundRosado, A., Vallcorba, O., Vázquez‐Lasa, B., García‐Fernández, L., Ramírez-Jiménez, R. A., Aguilar, M. R., López‐Periago, A. M., Domingo, C., & Ayllón, J. A. (2023) · Inorganic Chemistry Frontiers · doi:10.1039/d2qi02639b · Cited by 9
Zhu, W., Qiu, X., Xu, X., & Lu, C. (2010) · Science China Chemistry · doi:10.1007/s11426-010-4082-0 · Cited by 9
Inhibition of Multimolecular RNA–Protein Interactions Using Multitarget-Directed Nanohybrid System
Jeong, W., Kye, M., Han, S.-H., Choi, J. S., & Lim, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b01517 · Cited by 9
Kochanek, S. J., Close, D. A., Wang, A. X., Shun, T., Empey, P. E., Eiseman, J. L., & Johnston, P. A. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219844566 · Cited by 9
Kutluay, V. M., & Diker, N. Y. (2020) · PeerJ · doi:10.7717/peerj.10111 · Cited by 9
Homopharma: A new concept for exploring the molecular binding mechanisms and drug repurposing
Chiu, Y.-Y., Tseng, J.-H., Liu, K.-H., Lin, C.-T., Hsu, K., & Yang, J. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s9-s8 · Cited by 9
“cancer and central nervous system disorders) [7,8].”
Gnoth, K., Geißler, S., Feldhaus, J. S., Taudte, N., Ilse, V., Zürner, S., Greiser, S., Braumann, U., Rahfeld, J., Cynis, H., et al. (2022) · Biomolecules · doi:10.3390/biom12030399 · Cited by 9
Alsaed, A., Elshami, F. I., Ibrahim, M. M., Shereef, H. A., Mohany, H., van Eldik, R., & Shaban, S. Y. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105826 · Cited by 8
Semantic Breakthrough in Drug Discovery
Chen, B., Wang, H., Ding, Y., & Wild, D. J. (2015) · Synthesis lectures on data, semantics and knowledge · doi:10.1007/978-3-031-79456-8 · Cited by 8
New developments in small molecules targeting p53 pathways in anticancer therapy
Cheok, C. F., & Lane, D. P. (2008) · Drug Development Research · doi:10.1002/ddr.20261 · Cited by 12
“Screening a library of compounds that affects diverse molecular targets may produce novel and unexpected combination effects [Borisy et al., 2003; Keith et al., 2005].”
BackgroundCancer classification: Mutual information, target network and strategies of therapy
Hsu, W.-C., Liu, C.-C., Chang, F., & Chen, S. (2012) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-2-16 · Cited by 10
“Target network The effect of drugs with multiple components should be viewed as a whole rather than a superposition of individual components [1] [2].”
BackgroundWang, K., Wang, X., Hou, Y., Zhou, H., Mai, K., & He, G. (2019) · Communications Biology · doi:10.1038/s42003-019-0484-5 · Cited by 8
Rastelli, E. J., Sannino, S., Hart, D. J., Sharlow, E. R., Lazo, J. S., Brodsky, J. L., & Wipf, P. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128167 · Cited by 8
Hoch, M., Smita, S., Cesnulevicius, K., Schultz, M., Lescheid, D., Wolkenhauer, O., & Gupta, S. K. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00335-0 · Cited by 10
“While drug discovery remains highly focused on the one-molecule, one-target approach, clinical evidence often demonstrates limited effectiveness of single-component therapy [5, 6].”
BackgroundMoreno, G., Betancur-Zapata, E., Herrera‐Ramírez, A., & Cardona‐Galeano, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041221 · Cited by 8
Vertigoheel promotes rodent cognitive performance in multiple memory tests
Ott, K., Heikkinen, T., Lehtimäki, K. K., Paldanius, K. M. A., Puoliväli, J. T., Pussinen, R., Andriambeloson, E., Huyard, B., Wagner, S., Schnack, C., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1183023 · Cited by 10
“In this regard, multicomponent formulations may offer a possibility of engaging several molecular targets simultaneously (Keith et al., 2005).”
BackgroundBoller, M., Jung, S. K., Ødegaard, S., Muehlmatt, A., Katz, J. M., & Becker, L. B. (2011) · Resuscitation · doi:10.1016/s0300-9572(11)70148-4 · Cited by 8
Greco, G., Turrini, E., Tacchini, M., Maresca, I., & Fimognari, C. (2020) · Venoms and Toxins · doi:10.2174/2666121701999200601170928 · Cited by 8
“Many natural products could result in activities that later vanished when they are separated into individual chemical components [69].”
BackgroundClose, D. A., Kirkwood, J. M., Fecek, R. J., Storkus, W. J., & Johnston, P. A. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220970917 · Cited by 8
Network-Oriented Approaches to Anticancer Drug Response
Lecca, P., & Re, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6539-7_8 · Cited by 9
Synthesis of Chromen-4-One-Oxadiazole Substituted Analogs as Potent β-Glucuronidase Inhibitors
Taha, M., Rahim, F., Ali, M., Khan, M. N., Alqahtani, M. A., Bamarouf, Y. A., Gollapalli, M. A. S., Farooq, R. K., Shah, S. A. A., Ahmed, Q. U., et al. (2019) · Molecules · doi:10.3390/molecules24081528 · Cited by 8
A Modularity-Based Method Reveals Mixed Modules from Chemical-Gene Heterogeneous Network
Song, J., Tang, S., Liu, X., Gao, Y., Yang, H., & Lu, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125585 · Cited by 8
Naturally occurring multipotent anti-Alzheimer’s agents
Zhang, H., Yang, D., & Ji, H. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.3.269 · Cited by 9
“The first conceivable approach is a multicomponent strategy, which incorporates at least two active ingredients in one drug [13], as occurred in traditional medicine (in China and many other countries) and in cocktail drugs.”
BackgroundMedicinal Chemistry Approaches for Multitarget Drugs
Morphy, R., & Ranković, Z. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc124 · Cited by 8
Boonyarit, B., Kositchutima, M., Phattalung, T. N., Yamprasert, N., Thuwajit, C., Rungrotmongkol, T., & Nutanong, S. Y. (2025) · GigaScience · doi:10.1093/gigascience/giaf080 · Cited by 7
“Combination therapies or multitarget approaches, which target multiple pathways, offer improved efficacy, reduced resistance, and minimized adverse effects, making them essential for optimizing patient outcomes [ 7 ].”
Kaushik, A. C., Mehmood, A., Wei, D., Nawab, S., Sahi, S., & Kumar, A. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166037 · Cited by 8
Kossmann, D. F., Huang, M., Weihmann, R., Xiao, X., Gätgens, F., Weber, T. M., Brass, H. U. C., Bitzenhofer, N. L., Ibrahim, S. R. M., Bangert, K., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1151882 · Cited by 7
“Unlike “single compound - single target” approaches, multicomponent therapeutics enable interactions with multiple targets (Keith et al., 2005; Hopkins, 2007; Yildirim et al., 2007).”
BackgroundLiu, K., Xu, Y., Zhang, G., & Xiang, Z. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230614102412 · Cited by 7
Álvarez-Córdoba, M., Talaverón-Rey, M., Povea-Cabello, S., Cilleros-Holgado, P., Gómez-Fernández, D., Piñero-Pérez, R., Reche-López, D., Munuera-Cabeza, M., Suárez-Carrillo, A., Romero-González, A., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16101359 · Cited by 9
“Disadvantages of monotherapies can thus be overcome by designing drug combinations that modulate multiple targets [200].”
BackgroundMHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction
Li, L., Lü, G., Zheng, C.-H., Lin, R., & Su, Y. (2024) · Big Data Mining and Analytics · doi:10.26599/bdma.2024.9020054 · Cited by 8
An Integrative Thrombosis Network: Visualization and Topological Analysis
Kong, X., Zhou, W., Wan, J., Zhang, Q., Ni, J., & Yuanjia, H. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/265303 · Cited by 9
“On the other hand, the rapid progress of bioinformatics and systems biology has provided not only a systems-level understanding of biological processes and disease complexity but also an efficient and promising approach, such as network analysis, for integrative drug development [5, 11].”
BackgroundConvergent Evolution of Medicines
De, K., Li, X., & Zhang, H. (2008) · ChemMedChem · doi:10.1002/cmdc.200800093 · Cited by 7
Cross, K., Craggs, R., Swift, D., Sitaram, A., Daya, S., Roberts, M., Hawley, S. R., Owen, P., & Isherwood, B. J. (2015) · SLAS TECHNOLOGY · doi:10.1177/2211068215579163 · Cited by 7
“Thus, one strategy to bring improved success to drug discovery is the rational design of drug combinations and multitargeted therapeutics within early drug discovery.(7,8) In creating a drug-combination capability, the aim is to develop a scientific competency that integrates informatics, in silico, analytical, and ex…”
BackgroundMultifunctional Nanoscale Platforms for Targeting of the Cancer Cell Immortality Spectrum
Soundararajan, V., Warnock, K., & Sasisekharan, R. (2010) · Macromolecular Rapid Communications · doi:10.1002/marc.200900596 · Cited by 7
Fan, J.-R., Huang, T. H., Wen, C.-Y., Shen, T., & Li, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.012 · Cited by 7
“Multi-component therapeutics have provided an effective approach to overcomepoor efficacy, undesirable side effects and tumor resistance of target-specific drugs (Keith et al., 2005).”
BackgroundLi, H., Ung, C. Y., Xiao, H., Liu, X. H., Li, B. W., Low, B. C., & Chen, Y. (2009) · Cancer · doi:10.1002/cncr.24485 · Cited by 7
Systems Pharmacology: Enabling Multidimensional Therapeutics
Maudsley, S. R., Leysen, H., van Gastel, J., & Martin, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00017-7 · Cited by 6
Su, X., Li, R., Zhang, Z., Lu, L., Wang, S., & Liu, T. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119477 · Cited by 6
Barbari, R., Bruggink, V., Hofstetter, R. K., Tupini, C., Fagnani, S., Baldini, E., Durini, E., Lampronti, I., Vertuani, S., Baldisserotto, A., et al. (2024) · Antioxidants · doi:10.3390/antiox13101196 · Cited by 6
“These therapies target individual biological changes or symptoms rather than the entire disease [8].”
Gaikani, H. K., Smith, A. M., Lee, A. Y., Giaever, G. N., & Nislow, C. (2021) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2021.683414 · Cited by 7
“Drugs can be easily combined to simultaneously modulate multiple proteins’ activities, and in fact, the modulation of gene products by administering a combination of drugs can be vital for a successful course of treatment (Keith et al., 2005).”
BackgroundLiu, Y., Li, L., Xiao, Y., Yao, J., Li, P., Chen, L., Dingrong, Y., & Ma, Y. (2015) · Biomedical Chromatography · doi:10.1002/bmc.3673 · Cited by 6
Bifurcation-based approach reveals synergism and optimal combinatorial perturbation
Liu, Y., Li, S., Liu, Z., & Wang, R. (2016) · Journal of Biological Physics · doi:10.1007/s10867-016-9414-7 · Cited by 6
Drug development and clinical trial design in pancreatico-biliary malignancies
Harrington, J., Carter, L., Basu, B., & Cook, N. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.01.003 · Cited by 6
Williams, M. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00056-0 · Cited by 6
Kusuma, W. A., Habibi, Z. I., Amir, M. F., Fadli, A., Khotimah, H., Dewanto, V., & Heryanto, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.978741 · Cited by 5
“With the rapid advances in bioinformatics and systems biology, networkbased drug discovery is seen as a promising approach to more cost-effective drug discovery (Keith et al., 2005; Jia et al., 2009; Schadt et al., 2009; Zhang et al., 2019; Chaudhari et al., 2020; Noor et al., 2022).”
BackgroundMa, M., Zhong, J., Tai, Y., Xu, S., Pei, Z., & Wang, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-98209-3 · Cited by 5
“With the rapid development of bioinformatics, systems biology and pharmacology, network-based drug discovery is considered as a more efficient method to discover drug targets 16,17 .”
Silva‐García, M., Herrera‐Ramírez, A., Yepes, A. F., & Cardona‐Galeano, W. (2025) · ChemistrySelect · doi:10.1002/slct.202500902 · Cited by 5
Exploring the multifunctional potential of designed benzothiazole hydrazones
Barbari, R., Bruggink, V., Hofstetter, R. K., Tupini, C., Montani, L., Fagnani, S., Marchetti, F., Durini, E., Lampronti, I., Vertuani, S., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118511 · Cited by 5
Nasehi, P., Omidkhah, N., & Ghodsi, R. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108950 · Cited by 6
Greger, L. M., Greger, C., Hiller, K., & Maisch, T. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1645341 · Cited by 6
“Combinations of different antimicrobial substances (AMS) can exhibit effects that differ from what would be expected through the single application of the AMS (Choudhary et al., 2022; Coates et al., 2020; Keith et al., 2005).”
Huang, X., & Chen, D. Y. ‐. (2012) · ChemMedChem · doi:10.1002/cmdc.201200287 · Cited by 5
Zhang, S., Niu, Q., Song, Q., Song, Q., Tian, S., Wang, J., Liu, J. H., Zhang, H., Wang, Z., & Li, B. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118287 · Cited by 5
Wang, X., Yi, Z., Zhang, Y., Zhang, J., Li, X., Qi, D., Wang, Q., Chai, X., Liu, H., Wang, G., et al. (2025) · Molecules · doi:10.3390/molecules30040771 · Cited by 5
“PMFs in CRP exhibit multi-component characteristics, leading to complex pharmacokinetic and pharmacodynamic profiles [14].”
System Analysis of LWDH Related Genes Based on Text Mining in Biological Networks
Liao, M., Miao, Y., Zhang, L., Wang, Y., Feng, R., Yang, L., Zhang, S., Jiang, Y., & Liu, G. (2014) · BioMed Research International · doi:10.1155/2014/484926 · Cited by 5
Wang, C., Batey, R. G., Yamahara, J., & Li, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.040 · Cited by 5
Non-clinical similarity of biosimilar ABP 798 with rituximab reference product
McBride, H. J., Jassem, S., Chow, V., Kanakaraj, P., Lebrec, H. N., Kuhns, S. T., Ferbas, J., Wong, M., & Thway, T. M. (2021) · Biologicals · doi:10.1016/j.biologicals.2021.05.002 · Cited by 5
Semantic Breakthrough in Drug Discovery
Chen, B., Wang, H., Ding, Y., & Wild, D. J. (2014) · Synthesis lectures on the semantic web · doi:10.2200/s00600ed1v01y201409web009 · Cited by 6
Park, E. J., Lee, B.-W., Ryu, B., Cho, H. M., Kim, S. K., Yoo, S.-S., Kim, E., & Oh, W. K. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102315 · Cited by 5
“It has been shown that multicomponent therapeutics can act synergistically, a concept called multicomponent and multitarget (MCMT) in traditional Chinese medicine (TCM) (Keith et al., 2005; Dunning et al., 2014; Zhang et al., 2019).”
BackgroundIn Silico Prediction of Drug Side Effects
Keiser, M. J. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch02 · Cited by 5
Pooled Screening for Synergistic Interactions Subject to Blocking and Noise
Li, K., Precup, D., & Perkins, T. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085864 · Cited by 6
Zhou, T., He, L., Yan, M., Zhang, L., He, J., & Rao, X. (2013) · Chinese Journal of Natural Medicines · doi:10.3724/sp.j.1009.2013.00506 · Cited by 5
Deun, K. V., Thorrez, L., van den Berg, R. A., Smilde, A. K., & Mechelen, I. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125334 · Cited by 5
“In this regard, different types of interplay have been distinguished in the literature [5,6,7].”
Chem2Bio2RDF: A Linked Open Data Portal for Chemical BiologyPreprint
Chen, B., Wild, D. J., Zhu, Q., Ding, Y., Dong, X., Sankaranarayanan, M., Wang, H., & Sun, Y. (2010) · arXiv (Cornell University) · doi:10.48550/arxiv.1012.4759 · Cited by 5
Becerra-Quintana, R., Herrera‐Ramírez, A., Yepes, A. F., Cadavid-Arango, L., & Cardona‐Galeano, W. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03401-9 · Cited by 4
“2 Structures of potent anti-tumoral compounds incorporating a biphenyl portion (in magenta) and the stilbene framework (in red) biological target [35 – 38].”
Duan, X. W., Wang, X., Li, Z., Liu, C., Bao, Y., Shi, W., & Zhao, X. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1459188 · Cited by 4
“However, the factors influencing the health status of sows and their offspring piglets are exceedingly intricate, so the efficacy of a singular Chinese herbal medicine in addressing these complex issues arising from sows and their offspring piglets is often limited (Keith et al., 2005).”
BackgroundAhmed, N., Ibrahim, M. M., El‐Mehasseb, I. M., & Shaban, S. Y. (2024) · Carbohydrate Research · doi:10.1016/j.carres.2024.109292 · Cited by 4
Metadata
- Authors
- Keith, C. T., Borisy, A. A., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Corresponding author
- Keith, Curtis T.
- Borisy, Alexis A.
- Stockwell, Brent R.
- ORCID
- Stockwell, Brent R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-01
- Volume
- 4
- Issue
- 1
- Pages
- 71-78
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1592483428
- Cited by
- 769
- References
- 67
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 30 · 2023: 33 · 2022: 44 · 2021: 36 · 2020: 34 · 2019: 36 · 2018: 42 · 2017: 29 · 2016: 43 · 2015: 51 · 2014: 55 · 2013: 49 · 2012: 47
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- combination therapy, systems biology, mechanism of action, drug discovery
- MeSH terms
- Clinical Trials as Topic, Drug Synergism, Drug Therapy, Combination, Humans, Terminology as Topic, Drug Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.